Cambrex Corp (NYSE:CBM)

CAPS Rating: 4 out of 5

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.

Recs

0
Player Avatar 2win (< 20) Submitted: 11/4/2013 9:32:22 PM : Outperform Start Price: $17.80 CBM Score: -10.00

4th on list. http://www.bloomberg.com/visual-data/best-and-worst/most-efficient-companies

Featured Broker Partners


Advertisement